Skip to main content

Rifampin Injection

Last Updated: May 26, 2021
Status: Resolved

Reason for the Shortage
    • Fresenius Kabi stated the reason for the shortage was a short-term manufacturing delay.
    • Mylan had rifampin injection on shortage due to increased demand.
    • Sanofi-Aventis had Rifadin IV on shortage due to manufacturing delays.
Available Products
    • Rifadin IV lyophilized powder for injection, Sanofi-Aventis, 600 mg, vial, 1 count, NDC 00068-0597-01
    • Rifampin lyophilized powder for injection, Fresenius Kabi, 600 mg, vial, 1 count, NDC 63323-0351-20
    • Rifampin lyophilized powder for injection, Mylan Institutional, 600 mg, vial, 1 count, NDC 67457-0445-60

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated May 26, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 11, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.